![All lanes : Anti-IBRDC2 antibody [6B11] (ab114013) at 1/500 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY IBRDC2 cDNALysates/proteins at 5 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_3/6092_IBRDC2-Primary-antibodies-ab114013-2.jpg)
All lanes : Anti-IBRDC2 antibody [6B11] (ab114013) at 1/500 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY IBRDC2 cDNALysates/proteins at 5 µg per lane.
ab114013 at 1/100 dilution staining IBRDC2 in COS7 cells transiently transfected by pCMV6-ENTRY IBRDC2 and analyzed by immunofluorescence.
ab114013 staining IBRDC2 in HEK293T cells transfected with IBRDC2 overexpression plasmid (red) or empty vector control (blue), and analyzed by flow cytometry.
ab114013 staining IBRDC2 in HeLa cells (red) compared to a non-specific negative control (blue), and analyzed by flow cytometry.
ab114013 staining IBRDC2 in Jurkat cells (red) compared to a non-specific negative control (blue), and analyzed by flow cytometry.